Patents by Inventor Giuseppe Teti

Giuseppe Teti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides that mimic non-human cross-reactive protective epitopes of the group B meningococcal capsular polysaccharide
    Patent number: 8034349
    Abstract: Peptides that mimic the antigenic features of non human-cross-reactive protective epitopes of the MenB CP and nucleic acids encoding the peptide mimetics are disclosed. Antibodies elicited by these peptides do not bind to polysialic acid in host tissue and thus provide a safe and efficacious method for the treatment and/or prevention of Meningitis B.
    Type: Grant
    Filed: June 12, 2007
    Date of Patent: October 11, 2011
    Inventors: Giuseppe Teti, Franco Felici
  • PEPTIDES THAT MIMIC NON-HUMAN CROSS-REACTIVE PROTECTIVE EPITOPES OF THE GROUP B MENINGOCOCCAL CAPSULAR POLYSACCHARIDE
    Publication number: 20100068219
    Abstract: Peptides that mimic the antigenic features of non human-cross-reactive protective epitopes of the MenB CP and nucleic acids encoding the peptide mimetics are disclosed. Antibodies elicited by these peptides do not bind to polysialic acid in host tissue and thus provide a safe and efficacious method for the treatment and/or prevention of Meningitis B.
    Type: Application
    Filed: June 12, 2007
    Publication date: March 18, 2010
    Inventor: Giuseppe Teti
  • Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
    Patent number: 6900302
    Abstract: The invention relates to peptide, oligopeptide or polypeptide compounds that are capable of eliciting a protective immune response against the capsular polysaccharide of group B Streptococcus (GBS), particularly type III GBS. Such compounds are useful in the development of vaccines that are effective against diseases caused by these pathogens.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: May 31, 2005
    Assignee: Chiron S.r.l.
    Inventors: Giuseppe Teti, Luciano Polonelli
  • Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
    Publication number: 20040101536
    Abstract: The invention relates to peptide, oligopeptide or polypeptide compounds that are capable of eliciting a protective immune response against the capsular polysaccharide of group B Streptococcus (GBS), particularly type III GBS. Such compounds are useful in the development of vaccines that are effective against diseases caused by these pathogens.
    Type: Application
    Filed: November 7, 2003
    Publication date: May 27, 2004
    Applicant: Chiron S.P.A.
    Inventors: Giuseppe Teti, Luciano Polonelli
  • Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
    Patent number: 6676938
    Abstract: The invention relates to peptide, oligopeptide or polypeptide compounds that are capable of eliciting a protective immune response against the capsular polysaccharide of group B Streptococcus (GBS), particularly type III GBS. Such compounds are useful in the development of vaccines that are effective against diseases caused by these pathogens.
    Type: Grant
    Filed: May 17, 2001
    Date of Patent: January 13, 2004
    Assignee: Chiron S.r.L.
    Inventors: Giuseppe Teti, Luciano Polonelli